{"id":"https://openalex.org/W2188261574","doi":null,"title":"Second-line options for EGFR- and Alk-unmutated lung cancers Therapeutic decisionmaking in the molecular era","display_name":"Second-line options for EGFR- and Alk-unmutated lung cancers Therapeutic decisionmaking in the molecular era","publication_year":2014,"publication_date":"2014-01-01","ids":{"openalex":"https://openalex.org/W2188261574","mag":"2188261574"},"language":"en","primary_location":{"id":"mag:2188261574","doi":null,"is_oa":false,"landing_page_url":"http://www.oncologyex.com/pdf/vol13_no1/review_blais-second-line-lung.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018835840","display_name":"Normand Blais","orcid":"https://orcid.org/0000-0003-2698-4362","observed_orcids":["https://orcid.org/0000-0003-2698-4362"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Normand Blais","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2698-4362","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5018835840"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9649999737739563},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.9729999899864197},{"id":"https://openalex.org/keywords/egfr-mutation","display_name":"EGFR mutation","score":0.753000020980835},{"id":"https://openalex.org/keywords/alk-rearrangement","display_name":"ALK rearrangement","score":0.9980000257492065},{"id":"https://openalex.org/keywords/molecular-subtyping","display_name":"molecular subtyping","score":0.7979999780654907},{"id":"https://openalex.org/keywords/patient-selection","display_name":"patient selection","score":0.9769999980926514},{"id":"https://openalex.org/keywords/patient-preferences","display_name":"patient preferences","score":0.8109999895095825}],"concepts":[{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.6426002383232117},{"id":"https://openalex.org/C83852419","wikidata":"https://www.wikidata.org/wiki/Q2713292","display_name":"Subtyping","level":2,"score":0.6158822774887085},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5531764626502991},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5364736914634705},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5060786604881287},{"id":"https://openalex.org/C3019258254","wikidata":"https://www.wikidata.org/wiki/Q1423317","display_name":"Second line","level":3,"score":0.47074800729751587},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37661662697792053},{"id":"https://openalex.org/C2993493390","wikidata":"https://www.wikidata.org/wiki/Q5453208","display_name":"First line","level":2,"score":0.365550696849823},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.15965154767036438},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1225152313709259},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2188261574","doi":null,"is_oa":false,"landing_page_url":"http://www.oncologyex.com/pdf/vol13_no1/review_blais-second-line-lung.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W1839238860","https://openalex.org/W2045193617","https://openalex.org/W2070246207","https://openalex.org/W2077383408","https://openalex.org/W2097026987","https://openalex.org/W2099725888","https://openalex.org/W2100912832","https://openalex.org/W2101581271","https://openalex.org/W2112621029","https://openalex.org/W2114784462","https://openalex.org/W2128082578","https://openalex.org/W2130652363","https://openalex.org/W2134667653","https://openalex.org/W2136023414","https://openalex.org/W2138297714","https://openalex.org/W2156728903","https://openalex.org/W2167191456","https://openalex.org/W2315057422","https://openalex.org/W2598819900","https://openalex.org/W2599949378","https://openalex.org/W2603049692","https://openalex.org/W2603149418"],"related_works":["https://openalex.org/W2396325788","https://openalex.org/W1705461806","https://openalex.org/W2398853409","https://openalex.org/W2574335147","https://openalex.org/W2624631663","https://openalex.org/W2144434896","https://openalex.org/W2195845876","https://openalex.org/W2538933634","https://openalex.org/W4410809315","https://openalex.org/W2981565573"],"abstract_inverted_index":{"Current":[0],"treatment":[1,57],"based":[2],"algorithms":[3],"for":[4,40],"NSCLC":[5],"are":[6,34],"often":[7],"derived":[8],"from":[9],"studies":[10,33,73],"that":[11,21,74],"were":[12],"conducted":[13],"prior":[14],"to":[15,37],"the":[16,60,90,97],"extensive":[17],"wealth":[18],"of":[19,62,93],"knowledge":[20],"was":[22],"gained":[23],"by":[24],"subtyping":[25],"lung":[26],"cancer":[27],"into":[28,89],"distinct":[29],"molecular":[30,98],"entities.":[31],"New":[32],"now":[35],"helping":[36],"refine":[38],"strategies":[39],"second-line":[41,79],"approaches":[42],"in":[43,49,81,96],"EGFR-mutated,":[44],"Alk-rearranged,":[45],"as":[46,48],"well":[47],"EGFR/Alk-unmutated":[50],"tumours.":[51],"This":[52],"review":[53],"will":[54,84],"focus":[55],"on":[56],"decisions":[58,95],"after":[59],"failure":[61],"first-line":[63],"therapy,":[64],"considering":[65],"both":[66],"patient":[67,70],"selection":[68],"and":[69,87],"preferences.":[71],"Selected":[72],"have":[75],"specifically":[76],"looked":[77],"at":[78],"therapy":[80],"EGFR-negative":[82],"patients":[83],"be":[85],"reviewed":[86],"placed":[88],"current":[91],"context":[92],"therapeutic":[94],"era.":[99]},"counts_by_year":[],"updated_date":"2025-11-06T04:12:42.849631","created_date":"2016-06-24T00:00:00"}